{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:53:37Z","timestamp":1792036417594,"version":"4.4.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Somatic mutations of the CUT-like homeobox 1 (CUX1) gene (CUX1MT) can be found in myeloid neoplasms (MNs), in particular, in myelodysplastic syndromes (MDSs). The CUX1 locus is also deleted in 3 of 4 MN cases with \u22127\/del(7q). A cohort of 1480 MN patients was used to characterize clinical features and clonal hierarchy associated with CUX1MT and CUX1 deletions (CUX1DEL) and to analyze their functional consequences in vitro. CUX1MT were present in 4% of chronic MNs. CUX1DEL were preferentially found in advanced cases (6%). Most MDS and acute myeloid leukemia (AML) patients with \u22127\/del(7q) and up to 15% of MDS patients and 5% of AML patients diploid for the CUX1 locus exhibited downmodulated CUX1 expression. In 75% of mutant cases, CUX1MT were heterozygous, whereas microdeletions and homozygous and compound-heterozygous mutations were less common. CUXMT\/DEL were associated with worse survival compared with CUX1WT. Within the clonal hierarchy, 1 of 3 CUX1MT served as founder events often followed by secondary BCOR and ASXL1 subclonal hits, whereas TET2 was the most common ancestral lesion, followed by subclonal CUX1MT. Comet assay of patients\u2019 bone marrow progenitor cells and leukemic cell lines performed in various experimental conditions revealed that frameshift mutations, hemizygous deletions, or experimental CUX1 knockdown decrease the repair of oxidized bases. These functional findings may explain why samples with either CUX1MT or low CUX1 expression coincided with significantly higher numbers of somatic hits by whole-exome sequencing. Our findings implicate the DNA repair dysfunction resulting from CUX1 lesions in the pathogenesis of MNs, in which they lead to a mutator phenotype.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018028423","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T20:45:11Z","timestamp":1563482711000},"page":"2164-2178","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":41,"title":["Distinct clinical and biological implications of CUX1 in myeloid neoplasms"],"prefix":"10.1182","volume":"3","author":[{"given":"Mai","family":"Aly","sequence":"first","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"},{"name":"Clinical Hematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubaidah M.","family":"Ramdzan","sequence":"additional","affiliation":[{"name":"Rosalind and Morris Goodman Cancer Research Centre, Department of Oncology, Biochemistry and Medicine, McGill University, Montreal, QC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hosono","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Faculty of Medical Science, University of Fukui, Fukui, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Makishima","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Visconte","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Kuzmanovic","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Adema","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Nazha","sequence":"additional","affiliation":[{"name":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlomiej P.","family":"Przychodzen","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra M.","family":"Kerr","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[{"name":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Abazeed","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6125-0850","authenticated-orcid":false,"given":"Alain","family":"Nepveu","sequence":"additional","affiliation":[{"name":"Rosalind and Morris Goodman Cancer Research Centre, Department of Oncology, Biochemistry and Medicine, McGill University, Montreal, QC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"issue":"25","key":"2020021108172751600_B1","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1182\/blood-2011-12-397620","article-title":"Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis","volume":"119","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020021108172751600_B2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2011-01-331678","article-title":"Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression","volume":"118","author":"Klampfl","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2020021108172751600_B3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood-2012-04-426965","article-title":"CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia","volume":"121","author":"McNerney","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2020021108172751600_B4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/gcc.22001","article-title":"Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma","volume":"52","author":"Schoenmakers","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"2020021108172751600_B5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc3805","article-title":"CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers","volume":"14","author":"Ramdzan","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"7407","key":"2020021108172751600_B6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"issue":"6","key":"2020021108172751600_B7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccr.2005.05.018","article-title":"CUTL1 is a target of TGF(\u03b2) signaling that enhances cancer cell motility and invasiveness","volume":"7","author":"Michl","year":"2005","journal-title":"Cancer Cell"},{"issue":"8","key":"2020021108172751600_B8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/gut.2009.189720","article-title":"CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer","volume":"59","author":"Ripka","year":"2010","journal-title":"Gut"},{"issue":"1","key":"2020021108172751600_B9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2012.01.039","article-title":"CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases","volume":"497","author":"Hulea","year":"2012","journal-title":"Gene"},{"issue":"2","key":"2020021108172751600_B10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1097-2765(04)00209-6","article-title":"A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP\/Cux transcription factor","volume":"14","author":"Goulet","year":"2004","journal-title":"Mol Cell"},{"issue":"1","key":"2020021108172751600_B11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/nar\/gkm970","article-title":"Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes","volume":"36","author":"Harada","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2020021108172751600_B12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2164-14-258","article-title":"Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE array","volume":"14","author":"Vadnais","year":"2013","journal-title":"BMC Genomics"},{"issue":"18","key":"2020021108172751600_B13","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1128\/MCB.21.18.6332-6345.2001","article-title":"S phase-specific proteolytic cleavage is required to activate stable DNA binding by the CDP\/Cut homeodomain protein","volume":"21","author":"Moon","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2020021108172751600_B14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ng0492-50","article-title":"Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut","volume":"1","author":"Neufeld","year":"1992","journal-title":"Nat Genet"},{"issue":"10","key":"2020021108172751600_B15","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1128\/MCB.16.10.5346","article-title":"The human cut homeodomain protein can repress gene expression by two distinct mechanisms: active repression and competition for binding site occupancy","volume":"16","author":"Mailly","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"25","key":"2020021108172751600_B16","doi-asserted-by":"crossref","first-page":"16736","DOI":"10.1016\/S0021-9258(18)55363-1","article-title":"CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter","volume":"266","author":"Skalnik","year":"1991","journal-title":"J Biol Chem"},{"issue":"6","key":"2020021108172751600_B17","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.18632\/oncotarget.2919","article-title":"The function of CUX1 in oxidative DNA damage repair is needed to prevent premature senescence of mouse embryo fibroblasts","volume":"6","author":"Ramdzan","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"2020021108172751600_B18","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pbio.1001807","article-title":"RAS transformation requires CUX1-dependent repair of oxidative DNA damage","volume":"12","author":"Ramdzan","year":"2014","journal-title":"PLoS Biol"},{"issue":"12","key":"2020021108172751600_B19","doi-asserted-by":"crossref","first-page":"19021","DOI":"10.18632\/oncotarget.14875","article-title":"The DNA repair function of CUX1 contributes to radioresistance","volume":"8","author":"Ramdzan","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"2020021108172751600_B20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.3742","article-title":"Dynamics of clonal evolution in myelodysplastic syndromes","volume":"49","author":"Makishima","year":"2017","journal-title":"Nat Genet"},{"issue":"4","key":"2020021108172751600_B21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/bjh.12964","article-title":"The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7\/del(7q)","volume":"166","author":"McNerney","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2020021108172751600_B22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.12515","article-title":"The molecular pathogenesis of the myelodysplastic syndromes","volume":"95","author":"Pellagatti","year":"2015","journal-title":"Eur J Haematol"},{"issue":"8","key":"2020021108172751600_B23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ajh.22069","article-title":"Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPN","volume":"86","author":"Thoennissen","year":"2011","journal-title":"Am J Hematol"},{"issue":"4","key":"2020021108172751600_B24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"7","key":"2020021108172751600_B25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"issue":"1","key":"2020021108172751600_B26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng.2846","article-title":"Inactivating CUX1 mutations promote tumorigenesis","volume":"46","author":"Wong","year":"2014","journal-title":"Nat Genet"},{"issue":"13","key":"2020021108172751600_B27","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V98.13.3658","article-title":"Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice","volume":"98","author":"Sinclair","year":"2001","journal-title":"Blood"},{"issue":"2","key":"2020021108172751600_B28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br J Cancer"},{"issue":"19","key":"2020021108172751600_B29","doi-asserted-by":"crossref","first-page":"9492","DOI":"10.1158\/0008-5472.CAN-05-4230","article-title":"Transgenic mice expressing the p75 CCAAT-displacement protein\/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia","volume":"66","author":"Cadieux","year":"2006","journal-title":"Cancer Res"},{"issue":"6","key":"2020021108172751600_B30","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/leu.2014.25","article-title":"Recurrent genetic defects on chromosome 7q in myeloid neoplasms","volume":"28","author":"Hosono","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"2020021108172751600_B31","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/leu.2017.164","article-title":"Genomic determinants of chronic myelomonocytic leukemia","volume":"31","author":"Patel","year":"2017","journal-title":"Leukemia"},{"key":"2020021108172751600_B32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/asheducation-2007.1.392","article-title":"Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia","volume":"2007","author":"Pedersen-Bjergaard","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2020021108172751600_B33","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/j.clml.2018.07.177","article-title":"Mutational landscape of therapy-related myeloid neoplasms","volume":"18","author":"Kuzmanovic","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"2020021108172751600_B34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"2020021108172751600_B35","volume-title":"ISCN 1995: An International System for Human Cytogenetic Nomenclature","author":"Mitelman","year":"1995"},{"issue":"31","key":"2020021108172751600_B36","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1200\/JCO.2009.21.9840","article-title":"New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia","volume":"27","author":"Tiu","year":"2009","journal-title":"J Clin Oncol"},{"issue":"16","key":"2020021108172751600_B37","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2020021108172751600_B38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nbt0212-126a","article-title":"Life Technologies promises $1,000 genome","volume":"30","author":"DeFrancesco","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2020021108172751600_B39","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/gim.2015.180","article-title":"Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification","volume":"18","author":"Song","year":"2016","journal-title":"Genet Med"},{"issue":"D1","key":"2020021108172751600_B40","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2020021108172751600_B41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.dnarep.2006.08.003","article-title":"Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals","volume":"6","author":"Paz-Elizur","year":"2007","journal-title":"DNA Repair (Amst)"},{"issue":"20","key":"2020021108172751600_B42","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/0008-5472.CAN-13-1616","article-title":"Integrative radiogenomic profiling of squamous cell lung cancer","volume":"73","author":"Abazeed","year":"2013","journal-title":"Cancer Res"},{"key":"2020021108172751600_B43","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1038\/ncomms11428","article-title":"A genetic basis for the variation in the vulnerability of cancer to DNA damage","volume":"7","author":"Yard","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"2020021108172751600_B44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0019-9958(57)90116-X","article-title":"An informational measure of correlation","volume":"1","author":"Linfoot","year":"1957","journal-title":"Inf Control"},{"issue":"405","key":"2020021108172751600_B45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/01621459.1989.10478751","article-title":"Relative entropy measures of multivariate dependence","volume":"84","author":"Joe","year":"1989","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"2020021108172751600_B46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","article-title":"Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome","volume":"155","author":"Davoli","year":"2013","journal-title":"Cell"},{"issue":"17","key":"2020021108172751600_B47","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1101\/gad.200101","article-title":"The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle","volume":"15","author":"Ellis","year":"2001","journal-title":"Genes Dev"},{"issue":"5","key":"2020021108172751600_B48","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/MCB.22.5.1424-1437.2002","article-title":"Genetic ablation of the CDP\/Cux protein C terminus results in hair cycle defects and reduced male fertility","volume":"22","author":"Luong","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2020021108172751600_B49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-2141.1997.4373247.x","article-title":"Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-\u03b1 concentration","volume":"99","author":"Peddie","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"2020021108172751600_B50","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/neuonc\/nox178","article-title":"CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide","volume":"20","author":"Kaur","year":"2018","journal-title":"Neuro Oncol"},{"issue":"5","key":"2020021108172751600_B51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2009.05.006","article-title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene","volume":"137","author":"Luo","year":"2009","journal-title":"Cell"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/14\/2164\/1632175\/advances028423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/14\/2164\/1632175\/advances028423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T07:07:58Z","timestamp":1610521678000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/14\/2164\/260120\/Distinct-clinical-and-biological-implications-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":51,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,7,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018028423","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]}}}